Tecan Group AG (TCHBF)

400.00 0.00 (0.00%) USD  |  OTCM  |  May 31, 16:00
More

Tecan Group Total Assets (Quarterly): 2.469B for Dec. 31, 2023

Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2009. Upgrade now.
Date Value
December 31, 2023 2.469B
June 30, 2023 2.311B
June 30, 2023 2.311B
December 31, 2022 2.282B
June 30, 2022 2.220B
June 30, 2022 2.220B
December 31, 2021 2.184B
June 30, 2021 1.279B
June 30, 2021 1.279B
December 31, 2020 1.269B
June 30, 2020 1.018B
June 30, 2020 1.018B
December 31, 2019 969.91M
June 30, 2019 921.41M
June 30, 2019 921.41M
December 31, 2018 871.14M
June 30, 2018 806.23M
June 30, 2018 806.23M
December 31, 2017 825.35M
June 30, 2017 776.33M
June 30, 2017 776.33M
Date Value
December 31, 2016 725.58M
June 30, 2016 676.42M
June 30, 2016 676.42M
December 31, 2015 648.99M
June 30, 2015 607.74M
June 30, 2015 607.74M
December 31, 2014 558.50M
June 30, 2014 534.72M
June 30, 2014 534.72M
December 31, 2013 525.82M
June 30, 2013 454.01M
June 30, 2013 454.01M
December 31, 2012 463.13M
June 30, 2012 405.05M
June 30, 2012 405.05M
December 31, 2011 414.74M
June 30, 2011 422.41M
December 31, 2010 362.13M
June 30, 2010 262.90M
December 31, 2009 336.65M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

921.41M
Minimum
Jun 2019
2.469B
Maximum
Dec 2023
1.645B
Average
1.279B
Median
Jun 2021

Total Assets (Quarterly) Benchmarks

AC Immune SA 185.40M
CRISPR Therapeutics AG 2.439B
Addex Therapeutics Ltd 5.526M
NLS Pharmaceutics Ltd 1.847M

Total Assets (Quarterly) Related Metrics

Total Liabilities (Quarterly) 863.22M
Shareholders Equity (Quarterly) 1.606B